- Home
- MYSZ vs PALI Comparison
MYSZ vs PALI Comparison
Compare MYSZ & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYSZ
- PALI
- Stock Information
- Founded
- MYSZ 1999
- PALI 1996
- Country
- MYSZ Israel
- PALI United States
- Employees
- MYSZ N/A
- PALI N/A
- Industry
- MYSZ Computer Software: Prepackaged Software
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MYSZ Technology
- PALI Health Care
- Exchange
- MYSZ Nasdaq
- PALI Nasdaq
- Market Cap
- MYSZ 2.9M
- PALI 3.2M
- IPO Year
- MYSZ N/A
- PALI N/A
- Fundamental
- Price
- MYSZ $1.36
- PALI $0.72
- Analyst Decision
- MYSZ Strong Buy
- PALI Strong Buy
- Analyst Count
- MYSZ 1
- PALI 2
- Target Price
- MYSZ $3.00
- PALI $23.00
- AVG Volume (30 Days)
- MYSZ 3.7M
- PALI 45.4K
- Earning Date
- MYSZ 05-14-2025
- PALI 05-12-2025
- Dividend Yield
- MYSZ N/A
- PALI N/A
- EPS Growth
- MYSZ N/A
- PALI N/A
- EPS
- MYSZ N/A
- PALI N/A
- Revenue
- MYSZ $8,257,000.00
- PALI N/A
- Revenue This Year
- MYSZ $29.71
- PALI N/A
- Revenue Next Year
- MYSZ N/A
- PALI N/A
- P/E Ratio
- MYSZ N/A
- PALI N/A
- Revenue Growth
- MYSZ 18.02
- PALI N/A
- 52 Week Low
- MYSZ $1.01
- PALI $0.60
- 52 Week High
- MYSZ $9.40
- PALI $9.09
- Technical
- Relative Strength Index (RSI)
- MYSZ 48.75
- PALI 46.57
- Support Level
- MYSZ $1.01
- PALI $0.67
- Resistance Level
- MYSZ $1.61
- PALI $0.77
- Average True Range (ATR)
- MYSZ 0.16
- PALI 0.05
- MACD
- MYSZ 0.03
- PALI 0.02
- Stochastic Oscillator
- MYSZ 53.97
- PALI 54.90
About MYSZ My Size Inc.
My Size Inc is a USA-based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers and licensing cloud-enabled software subscriptions, associated software maintenance, and support.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.